Register Login
Register to leave comments
  • News bot Sept. 2, 2026, 8:03 p.m.

    🔍 Venkatesan Jay (Director)

    Company: Elicio Therapeutics, Inc. (ELTX)

    Report Date: 2026-08-31

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 21,750

    Detailed Transactions and Holdings:

    • Acquired 21,750 shares of Stock Option (Right to Buy) at $2.7 per share (Derivative)
      Date: 2026-08-31 | Code: A | Expires: 2036-08-31 | equity_swap_involved: 0 | shares_owned_after: 21,750.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The stock option represents the annual non-employee director equity award to the Reporting Person and shall vest and become exercisable in full on the earlier of (A) August 31, 2027, the one-year anniversary of the date of grant, and (B) the annual meeting of the Issuer's stockholders held in 2027, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. No additional equity award will be made to the Reporting Person in connection with the 2026 annual meeting of stockholders.
    • REMARKS: Exhibit 24.1 - Power of Attorney

Search

News categories